Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
Saved in:
| Published in: | JAAD international Vol. 7; pp. 144 - 145 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01-06-2022
Elsevier |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Author | Ortega, Melissa Konnikov, Nellie Learned, Christine Deverapalli, Sandhya Alsukait, Sara Sobell, Jeffrey Rosmarin, David Elliott, Erika Moody, Katherine |
|---|---|
| Author_xml | – sequence: 1 givenname: Christine surname: Learned fullname: Learned, Christine organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 2 givenname: Sara surname: Alsukait fullname: Alsukait, Sara organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 3 givenname: Sandhya surname: Deverapalli fullname: Deverapalli, Sandhya organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 4 givenname: Erika surname: Elliott fullname: Elliott, Erika organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 5 givenname: Katherine surname: Moody fullname: Moody, Katherine organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 6 givenname: Jeffrey surname: Sobell fullname: Sobell, Jeffrey organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts – sequence: 7 givenname: Nellie surname: Konnikov fullname: Konnikov, Nellie organization: Department of Dermatology, Boston VA Medical Center, Boston, Massachusetts – sequence: 8 givenname: Melissa surname: Ortega fullname: Ortega, Melissa organization: Department of Pharmacy, Tufts Medical Center, Boston, Massachusetts – sequence: 9 givenname: David orcidid: 0000-0003-2786-0708 surname: Rosmarin fullname: Rosmarin, David email: drosmarin@tuftsmedicalcenter.org organization: Department of Dermatology, Tufts Medical Center, Boston, Massachusetts |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35497638$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1DAUhiNUREvpC7BAXrKZ4FscW0JIVWmhUiUQLWvLsU-mHk3swc6M1B2vgXg7ngRnUqp2w8r2uXzn4v9ldRBigKp6TXBNMBHvVvXK-VBTTGmNWY0JflYdUSHEglHZHjy6H1YnOa8wxrQhREn8ojpkDVetYPKo-v01x-RN9hkZt4OUAcEOwliewSGTc7TejODQAM5bM_oYiiujBJuYJrsPaLwF9P0aXcTo9lkf03aJTt3gg89j2uf8-fkrF9Nc4HwqgL7tCT4s0fVdHmFAfYoDomU2NMZyUvKqet6bdYaT-_O4urk4vzn7vLj68uny7PRqYTkTeCGd6LjFqidGGspb6kAqzoFwahQRrRGiU52jjgFWwFohbSc7Ihy1RvKWHVeXM9ZFs9Kb5AeT7nQ0Xu8NMS21KY3aNWjeN8oJ4pRhlFPaKGZZQxrDuaDY2KawPsyszbYrG7Nl0GTWT6BPPcHf6mXcaYXLLAIXwNt7QIo_tpBHPfhsYb02AeI2ayoaKTiVcuqbzqE2xZwT9A9lCNaTRvRKTxrRk0Y0ZrpopCS9edzgQ8o_RZSA93MAlI3vPCSdrYdgy_cnsGPZif8f_y8nYNCT |
| CitedBy_id | crossref_primary_10_1016_j_jaad_2023_02_006 |
| Cites_doi | 10.1007/s11606-020-06146-w 10.1684/ejd.2021.4056 10.1056/NEJMoa2028700 |
| ContentType | Journal Article |
| Copyright | 2022 American Academy of Dermatology, Inc. 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. 2022 American Academy of Dermatology, Inc. |
| Copyright_xml | – notice: 2022 American Academy of Dermatology, Inc. – notice: 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. 2022 American Academy of Dermatology, Inc. |
| DBID | 6I. AAFTH NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.jdin.2022.03.010 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2666-3287 |
| EndPage | 145 |
| ExternalDocumentID | oai_doaj_org_article_4f59d61d9a32422593c3515a44620ac5 10_1016_j_jdin_2022_03_010 35497638 S2666328722000396 |
| Genre | Journal Article |
| GroupedDBID | .1- .FO 1P~ 6I. AAEDW AAFTH AAXUO AFCTW AFRHN AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FDB GROUPED_DOAJ M41 M~E OK1 ROL RPM Z5R 0R~ 0SF AALRI ADVLN AFJKZ AITUG NPM AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c4360-8d6b4c09f1a8a2472de8944e142a9167a66b9bd2d3e09e3768cb8b16d2ca8473 |
| IEDL.DBID | RPM |
| ISSN | 2666-3287 |
| IngestDate | Tue Oct 22 15:11:02 EDT 2024 Tue Sep 17 21:28:05 EDT 2024 Fri Oct 25 11:48:39 EDT 2024 Thu Nov 21 22:20:11 EST 2024 Sat Sep 28 08:19:47 EDT 2024 Thu Jul 20 20:09:54 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | drug-induced psoriasis immunodermatology adverse events drug reactions psoriasis |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4360-8d6b4c09f1a8a2472de8944e142a9167a66b9bd2d3e09e3768cb8b16d2ca8473 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-2786-0708 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043660/ |
| PMID | 35497638 |
| PQID | 2658642887 |
| PQPubID | 23479 |
| PageCount | 2 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4f59d61d9a32422593c3515a44620ac5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043660 proquest_miscellaneous_2658642887 crossref_primary_10_1016_j_jdin_2022_03_010 pubmed_primary_35497638 elsevier_sciencedirect_doi_10_1016_j_jdin_2022_03_010 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-06-01 |
| PublicationDateYYYYMMDD | 2022-06-01 |
| PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAAD international |
| PublicationTitleAlternate | JAAD Int |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Awad, Sakhamuru, Kambampati, Wasim, Malik (bib5) 2020; 12 Elavarasi, Prasad, Seth (bib2) 2020; 35 Kim, Del Rosso (bib1) 2010; 3 Karamanakos, Vergou, Panopoulos, Tektonidou, Stratigos, Sfikakis (bib4) 2021; 31 Rosas, Bräu, Waters (bib3) 2021; 384 Karamanakos (10.1016/j.jdin.2022.03.010_bib4) 2021; 31 Kim (10.1016/j.jdin.2022.03.010_bib1) 2010; 3 Awad (10.1016/j.jdin.2022.03.010_bib5) 2020; 12 Rosas (10.1016/j.jdin.2022.03.010_bib3) 2021; 384 Elavarasi (10.1016/j.jdin.2022.03.010_bib2) 2020; 35 |
| References_xml | – volume: 3 start-page: 32 year: 2010 end-page: 38 ident: bib1 article-title: Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance publication-title: J Clin Aesthet Dermatol contributor: fullname: Del Rosso – volume: 12 year: 2020 ident: bib5 article-title: Mechanisms of beta-blocker induced psoriasis, and psoriasis de novo at the cellular level publication-title: Cureus contributor: fullname: Malik – volume: 31 start-page: 307 year: 2021 end-page: 317 ident: bib4 article-title: Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy publication-title: Eur J Dermatol contributor: fullname: Sfikakis – volume: 35 start-page: 3308 year: 2020 end-page: 3314 ident: bib2 article-title: Chloroquine and hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis publication-title: J Gen Intern Med contributor: fullname: Seth – volume: 384 start-page: 1503 year: 2021 end-page: 1516 ident: bib3 article-title: Tocilizumab in hospitalized patients with severe COVID-19 pneumonia publication-title: N Engl J Med contributor: fullname: Waters – volume: 35 start-page: 3308 issue: 11 year: 2020 ident: 10.1016/j.jdin.2022.03.010_bib2 article-title: Chloroquine and hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis publication-title: J Gen Intern Med doi: 10.1007/s11606-020-06146-w contributor: fullname: Elavarasi – volume: 3 start-page: 32 issue: 1 year: 2010 ident: 10.1016/j.jdin.2022.03.010_bib1 article-title: Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance publication-title: J Clin Aesthet Dermatol contributor: fullname: Kim – volume: 31 start-page: 307 issue: 3 year: 2021 ident: 10.1016/j.jdin.2022.03.010_bib4 article-title: Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy publication-title: Eur J Dermatol doi: 10.1684/ejd.2021.4056 contributor: fullname: Karamanakos – volume: 12 issue: 7 year: 2020 ident: 10.1016/j.jdin.2022.03.010_bib5 article-title: Mechanisms of beta-blocker induced psoriasis, and psoriasis de novo at the cellular level publication-title: Cureus contributor: fullname: Awad – volume: 384 start-page: 1503 issue: 16 year: 2021 ident: 10.1016/j.jdin.2022.03.010_bib3 article-title: Tocilizumab in hospitalized patients with severe COVID-19 pneumonia publication-title: N Engl J Med doi: 10.1056/NEJMoa2028700 contributor: fullname: Rosas |
| SSID | ssj0002511980 |
| Score | 2.236622 |
| SourceID | doaj pubmedcentral proquest crossref pubmed elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 144 |
| SubjectTerms | adverse events drug reactions drug-induced psoriasis immunodermatology psoriasis Research Letter |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELVKDxUXBLRAWkCu1BuK6thexz62dFe9gJDaStwsx3Zge0hQ073zGxV_x5cwY2dXG5DgwilaZzeOdyZ-b-LxG0JOWs8j0FBTKhZNKb0RZeMgStGVQ77sZ63C3ciXV_XHz_pijjI5m1JfmBOW5YHzH3cq25kJqgrGIfQDWRdeAAY7CGM4cz6rlzK1FUzhHIzE2aSyaQBAqhQQF4w7ZnJy1y0AAwSHnCeFU9w-u4VKSbx_Ak5_ks_fcyi3QGnxlDwZ2SQ9y6N4RnZi95zsfRjXy_fJj09DDx42LAfqsPLyEGlSbIKPXaBuNE0MNC2x55d30EzzSgK0LzsKDJHeXNFF34f0q4u71Rc61dz9-f1hoGdjB3PsgGZiD7hIsyY6xX0sFHiAovc9HHl1QK4X8-v3l-VYjqH0UigwX1CN9My0ldOOy5qHqI2UsZLcAcmsnVKNaQIPIjITYeLSvtFNpQL3DjBQvCC7Xd_FV5hOpV0Vg5QBc-RibTx4kpG8ZtqwVlYFebe2hv2WRTfsOhvt1qLtLNrOMmHBdgU5R4NtvomC2akB3MiObmT_5UYFma3NbUfukTkFXGr5186P175h4cHE1RbXxX41WA7cDoM7XRfkZfaVzS0KiMphYtcFqSdeNBnD9Ey3_JrEvw3WDFDs8H8M-og8xqHkzLfXZPf-bhXfkEdDWL1Nj9MvHA0hxg priority: 102 providerName: Directory of Open Access Journals |
| Title | Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021 |
| URI | https://dx.doi.org/10.1016/j.jdin.2022.03.010 https://www.ncbi.nlm.nih.gov/pubmed/35497638 https://search.proquest.com/docview/2658642887 https://pubmed.ncbi.nlm.nih.gov/PMC9043660 https://doaj.org/article/4f59d61d9a32422593c3515a44620ac5 |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWYLhAbxJvwqIzEDqWTOI5jL0s7o26KKrVI7CzHdkoqmlSTzp7fqPp3fAn32knVgMSCVRTnYSf3Ovfc-PiYkI-NZR5gqEpF5lXKrSrS2kCWInODeNmWjcDZyEen1Zdv8nCFMjnlNBcmkPZt3e51Py73uvZ74FZeXdrlxBNbnhwfKNRNF9lyQRaADe-l6Pj5RcysZDZOkIlcrguIA5ALMhYETXNc_q2AxAj6lpzFoyDbPwtLf8POP9mT98LR-gl5POJIuh_b-5Q88N0z8vB4HCl_Tm5Phh58a2gHanDN5cHToNUEu52jZjSKdzQMrsffdlBM4xgClLcdBWxIv57Sdd-7cNXhZntO52q7v37eDHR_rGCFFdAI6SEi0qiGTnEGCwUEIOh1D1uWvyBn69XZwVE6LsSQWnjRYDgnam4z1eRGGsYr5rxUnPucMwPwsjJC1Kp2zBU-Ux4-WdLWss6FY9ZA9Ctekp2u7_xrJFJJk3vHuUN2nK-UBR9SnFWZVFnD84R8mqyhr6Lchp54aBcazajRjDorNJgxIZ_RYHdnolR2KOg353p0GM2bUjmRO2UQO0K2V9gCQJyBPJhlxpYJKSdz6xF1RDQBt2r_WfmHyTc0dEkcZzGd77eDZoDqMK2TVUJeRV-5a-LkdgmpZl40e4b5EegFQfZ79Po3_33lW_II2x-Jbu_IzvVm69-TxeC2u-FXxG7oSL8BfU8i0A |
| link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXYkIAXvgfh00i8oa6O4yT249haFbFOk1Yk3izHdkYmlkzN-s7fQPw7fgn3xsm0gMTDnqo6TV3rHueeWx8fE_K-tNwDDVWTjHk1EVYlk8JAlSJjg3zZpmWGu5EXJ_nRV3kwQ5ucdNgL04n2bVHt1t_Pd-vqW6etvDi300EnNj1e7iv0Tc_YdIvchvnK2LUiHR_AyJqVZP0WmaDmOoNMANUg552laYwHwCVQGsHskqOM1Bn3jxLTv8Tzb_3ktYQ0f3DDoTwk93sGSvfC5Ufklq8fkzvLfo39Cfl13DaAyrZqqcHTmltPO5cneFs7avpweke7Zfnwhx8007D6AO1VTYFV0i8ndN40rrvrYL05pWOf3t8_frZ0r-9ghh3QUAxALqXBR53i3hcK3CGjlw288vgpWc1nq_3FpD_CYWJhXBBylxXCMlXGRhoucu68VEL4WHADxDQ3WVaownGXeKY8POykLWQRZ45bA3kz2SHbdVP75yjBkib2TgiHujqfKwvoU4LnTCpWijgiH4Yo6otg1KEHBduZxvBrDL9miYbwR-QjBvrqk2iy3TU061Pdx0eLMlUui50yyDqhTkxsAvTPQAXNmbFpRNIBJrrnK4GHwFdV_-383YApDZMZV2hM7ZtNqznwQSwIZR6RZwFjVz9xgGtE8hH6RmMYXwHQdYbhPche3PjOt-TuYrU81Iefjj6_JPdwLEEu94psX643_jXZat3mTTcN_wD7ejdf |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLXYkCZe-P4In0biDWV1HDexH8faagg2VdqQeLMc2xmZWFI16zt_A_Hv-CXc6yTVAhIP8FTVTepa9zj33Pr4mJA3peUeaKiKM-ZVLKxK48JAlSITg3zZTssMdyMfneYnn-VsjjY526O-gmjfFtV-_fVyv66-BG3l6tJOBp3YZHl8qNA3PWOTlSsnO-QmzFnGrxXq-BBG5qwk67fJdIquC8gGUBFyHmxNEzwELoXyCGaYHGWlYN4_Sk5_ks_fNZTXktLizn8M5y653TNRetBdco_c8PV9snfcr7U_ID-WbQPobKuWGjy1ufU0uD3B29pR04fVOxqW57s__qCZdqsQ0F7VFNgl_XRKF03jwl2z9eacjv16f3773tKDvoM5dkC7ogByKu381CnugaHAITJ61cArTx6Ss8X87PAo7o9yiC2MDULvskJYpsrESMNFzp2XSgifCG6AoOYmywpVOO5Sz5SHh560hSySzHFrIH-mj8hu3dT-CUqxpEm8E8Khvs7nygIKleA5k4qVIonI2yGSetUZduhByXahEQIaIaBZqgECEXmHwd5eiWbboaFZn-s-RlqUU-WyxCmD7BPqxdSmQAMNVNKcGTuNyHSAiu55S8dH4Kuqv3b-esCVhkmNKzWm9s2m1Rx4IRaGMo_I4w5n2584QDYi-QiBozGMPwHgBePwHmhP__nOV2RvOVvoj-9PPjwjt3AonWruOdm9Wm_8C7LTus3LMBN_Aa2LOd8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psoriasis+adverse+events+and+associated+medications+as+reported+in+the+US+Food+and+Drug+Administration%E2%80%99s+Adverse+Event+Reporting+System+from+2016+to+2021&rft.jtitle=JAAD+international&rft.au=Learned%2C+Christine&rft.au=Alsukait%2C+Sara&rft.au=Deverapalli%2C+Sandhya&rft.au=Elliott%2C+Erika&rft.date=2022-06-01&rft.pub=Elsevier+Inc&rft.issn=2666-3287&rft.eissn=2666-3287&rft.volume=7&rft.spage=144&rft.epage=145&rft_id=info:doi/10.1016%2Fj.jdin.2022.03.010&rft.externalDocID=S2666328722000396 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2666-3287&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2666-3287&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2666-3287&client=summon |